Forte Biosciences Balance Sheet (2016-2026) | FBRX

Balance Sheet Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
45.66M42.04M40.03M38.50M44.05M41.10M35.90M20.44M46.19M37.12M30.44M24.50M16.40M22.24M45.86M106.10M93.40M76.96M58.20M198.50M
Short-term Investments (Quarter)
9.99M36.12M148.83M
Cash & Current Investments (Quarter)
45.66M42.04M40.03M38.50M44.05M41.10M35.90M30.43M46.19M37.12M30.44M24.50M16.40M58.37M45.86M106.10M93.40M76.96M58.20M347.33M
Prepaid Assets (Quarter)
0.89M0.48M0.29M0.09M0.12M0.07M0.26M0.32M0.92M0.32M0.23M0.21M0.27M0.29M1.30M0.21M0.47M3.63M6.89M4.64M
Current Assets (Quarter)
46.56M42.52M40.41M38.85M44.59M41.51M36.27M30.75M47.10M38.33M31.50M25.71M17.67M61.35M47.16M107.62M95.41M80.59M65.11M203.10M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.03M0.10M0.11M0.11M0.10M0.09M0.08M0.12M0.11M0.15M0.13M0.11M0.09M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)
0.01M0.01M0.01M0.87M0.01M0.01M0.01M0.41M0.68M0.54M0.41M0.06M0.19M0.14M0.03M0.03M1.53M2.06M2.00M2.55M
Non-Current Assets (Quarter)
0.83M0.79M0.89M0.87M0.53M0.49M0.44M0.44M0.78M0.65M0.52M0.37M0.28M0.21M0.30M0.17M1.68M2.19M2.11M2.64M
Assets (Quarter)
47.39M43.31M41.30M39.72M45.13M42.00M36.71M31.18M47.88M38.98M32.02M26.08M17.95M61.56M47.46M107.78M97.09M82.78M67.22M205.74M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.33M0.95M0.58M0.70M1.19M1.15M1.34M3.01M5.35M1.42M1.69M5.28M5.16M4.88M5.02M5.30M5.49M9.99M13.08M14.01M
Notes Payables (Quarter)
Payables (Quarter)
2.33M0.95M0.58M0.70M1.19M1.15M1.34M3.01M5.35M1.42M1.69M5.28M5.16M4.88M5.02M5.30M5.49M9.99M13.08M14.01M
Accumulated Expenses (Quarter)
1.41M0.81M0.36M0.45M0.64M2.03M2.42M3.29M2.12M0.95M1.65M3.84M1.22M1.55M1.25M0.93M1.33M2.25M10.56M6.28M
Other Accumulated Expenses (Quarter)
0.06M0.02M0.14M0.05M0.03M0.01M0.06M0.04M0.07M0.00M0.01M0.01M0.13M0.11M0.08M0.03M0.01M0.08M0.08M
Current Leases (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)
3.74M1.76M1.26M1.51M2.29M3.18M3.76M6.30M7.47M3.67M3.33M9.12M8.58M9.08M9.03M9.17M12.99M20.75M23.65M20.29M
Non-Current Liabilities
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
Other Non-Current Liabilities (Quarter)
1.04M1.48M1.66M
Total Non-Current Liabilities (Quarter)
20.75M23.65M20.29M
Total Liabilities (Quarter)
47.39M43.31M41.30M39.72M45.13M42.00M36.71M31.18M47.88M38.98M32.02M26.08M17.95M9.08M47.46M107.78M97.09M21.79M25.12M21.95M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)
43.65M41.55M40.05M38.21M42.84M38.82M32.95M24.88M40.41M35.31M28.68M16.96M9.37M52.48M38.43M98.61M84.10M60.99M42.10M183.79M
Liabilities and Shareholders Equity (Quarter)
47.39M43.31M41.30M39.72M45.13M42.00M36.71M31.18M47.88M38.98M32.02M26.08M17.95M61.56M47.46M107.78M97.09M82.78M67.22M205.74M
Retained Earnings (Quarter)
-69.80M-73.17M-75.70M-78.77M-82.20M-87.04M-93.80M-102.69M-112.65M-118.52M-125.94M-0.01M-146.80M-154.00M-169.65M-180.90M-0.01M-223.37M-245.50M-268.84M
Treasury Shares (Quarter)
0.01M0.26M0.26M0.26M0.16M0.16M1.26M1.19M1.12M0.04M0.90M0.84M0.03M0.03M0.03M0.05M0.02M0.05M0.39M0.59M